Concepts (159)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Killer Cells, Natural | 11 | 2021 | 2093 | 1.73 | Why? |
| Immunity, Innate | 7 | 2021 | 6570 | 0.68 | Why? |
| Single-Cell Analysis | 4 | 2021 | 2450 | 0.63 | Why? |
| Influenza A Virus, H3N2 Subtype | 1 | 2018 | 572 | 0.52 | Why? |
| Sequence Analysis, RNA | 2 | 2021 | 2290 | 0.46 | Why? |
| Gene Expression Profiling | 4 | 2021 | 3788 | 0.45 | Why? |
| Leukocytes, Mononuclear | 2 | 2021 | 2115 | 0.44 | Why? |
| Orthomyxoviridae Infections | 1 | 2018 | 1001 | 0.43 | Why? |
| Interferon-gamma | 2 | 2018 | 2711 | 0.38 | Why? |
| Gene Expression Regulation | 3 | 2018 | 4020 | 0.37 | Why? |
| Research Personnel | 1 | 2018 | 1037 | 0.35 | Why? |
| Immunity, Cellular | 1 | 2020 | 3614 | 0.33 | Why? |
| Immunity | 2 | 2021 | 2651 | 0.28 | Why? |
| Influenza A Virus, H1N1 Subtype | 2 | 2020 | 2984 | 0.28 | Why? |
| Cytokines | 6 | 2021 | 15010 | 0.25 | Why? |
| Disease Susceptibility | 1 | 2015 | 4002 | 0.23 | Why? |
| Education, Medical | 1 | 2018 | 2461 | 0.22 | Why? |
| Hematopoiesis | 1 | 2021 | 168 | 0.21 | Why? |
| Tissue Culture Techniques | 1 | 2020 | 158 | 0.20 | Why? |
| HIV-1 | 1 | 2015 | 3365 | 0.20 | Why? |
| Interleukin-2 Receptor beta Subunit | 1 | 2019 | 17 | 0.20 | Why? |
| Nectins | 1 | 2018 | 8 | 0.19 | Why? |
| Physicians | 1 | 2018 | 4214 | 0.19 | Why? |
| Intercellular Adhesion Molecule-1 | 1 | 2018 | 189 | 0.17 | Why? |
| NK Cell Lectin-Like Receptor Subfamily K | 1 | 2017 | 35 | 0.17 | Why? |
| Training Support | 1 | 2018 | 131 | 0.17 | Why? |
| Receptors, IgG | 1 | 2020 | 578 | 0.16 | Why? |
| Complement System Proteins | 1 | 2020 | 380 | 0.16 | Why? |
| Polyethylene Glycols | 1 | 2021 | 574 | 0.16 | Why? |
| National Institutes of Health (U.S.) | 1 | 2018 | 443 | 0.15 | Why? |
| West Nile virus | 1 | 2017 | 206 | 0.15 | Why? |
| Immunologic Memory | 2 | 2018 | 3362 | 0.15 | Why? |
| Interleukins | 1 | 2021 | 762 | 0.15 | Why? |
| Myeloid Cells | 1 | 2020 | 808 | 0.14 | Why? |
| Epigenesis, Genetic | 1 | 2021 | 711 | 0.14 | Why? |
| West Nile Fever | 1 | 2017 | 166 | 0.14 | Why? |
| Physicians, Women | 1 | 2018 | 221 | 0.14 | Why? |
| Histocompatibility Antigens Class I | 1 | 2019 | 624 | 0.14 | Why? |
| Immune Tolerance | 1 | 2019 | 608 | 0.14 | Why? |
| Organoids | 1 | 2020 | 840 | 0.13 | Why? |
| NF-kappa B | 1 | 2021 | 1301 | 0.13 | Why? |
| Influenza, Human | 1 | 2018 | 10779 | 0.13 | Why? |
| Case-Control Studies | 3 | 2021 | 17671 | 0.13 | Why? |
| Education | 1 | 2018 | 434 | 0.13 | Why? |
| Lung | 2 | 2020 | 31049 | 0.12 | Why? |
| Career Choice | 1 | 2018 | 498 | 0.12 | Why? |
| Kenya | 1 | 2015 | 887 | 0.12 | Why? |
| T-Lymphocytes | 2 | 2020 | 6670 | 0.12 | Why? |
| Dengue Virus | 1 | 2019 | 910 | 0.11 | Why? |
| Environment | 1 | 2018 | 769 | 0.11 | Why? |
| Monocytes | 2 | 2021 | 2978 | 0.11 | Why? |
| Severity of Illness Index | 6 | 2021 | 48226 | 0.11 | Why? |
| Up-Regulation | 1 | 2019 | 2249 | 0.11 | Why? |
| Interferon-alpha | 1 | 2018 | 1442 | 0.10 | Why? |
| Proteomics | 1 | 2021 | 2481 | 0.10 | Why? |
| Age Distribution | 1 | 2018 | 3567 | 0.09 | Why? |
| Immune Evasion | 1 | 2018 | 2081 | 0.09 | Why? |
| Interleukin-15 | 2 | 2019 | 169 | 0.09 | Why? |
| Minority Groups | 1 | 2018 | 1631 | 0.09 | Why? |
| Cells, Cultured | 1 | 2018 | 5835 | 0.08 | Why? |
| Mice | 4 | 2021 | 21357 | 0.08 | Why? |
| Dengue | 1 | 2019 | 1565 | 0.08 | Why? |
| Tissue Donors | 1 | 2015 | 1679 | 0.07 | Why? |
| B-Lymphocytes | 1 | 2020 | 4418 | 0.07 | Why? |
| Pneumonia, Viral | 5 | 2020 | 243684 | 0.07 | Why? |
| Coronavirus Infections | 4 | 2020 | 253789 | 0.07 | Why? |
| Neutrophils | 1 | 2021 | 5476 | 0.07 | Why? |
| Humans | 20 | 2021 | 930598 | 0.07 | Why? |
| Models, Biological | 1 | 2020 | 4907 | 0.06 | Why? |
| Sepsis | 1 | 2020 | 3517 | 0.06 | Why? |
| Animals | 5 | 2021 | 78931 | 0.06 | Why? |
| Middle Aged | 9 | 2021 | 270681 | 0.06 | Why? |
| Immunophenotyping | 2 | 2019 | 1290 | 0.06 | Why? |
| Adult | 9 | 2021 | 244371 | 0.06 | Why? |
| Female | 10 | 2021 | 380317 | 0.06 | Why? |
| Integrin beta4 | 1 | 2020 | 35 | 0.06 | Why? |
| Integrin alpha6 | 1 | 2020 | 35 | 0.06 | Why? |
| Aged | 8 | 2021 | 215776 | 0.06 | Why? |
| 3T3 Cells | 1 | 2021 | 152 | 0.06 | Why? |
| TWEAK Receptor | 1 | 2020 | 46 | 0.06 | Why? |
| Keratin-5 | 1 | 2020 | 46 | 0.06 | Why? |
| Cell Division | 1 | 2020 | 136 | 0.05 | Why? |
| Immunogenetics | 1 | 2020 | 124 | 0.05 | Why? |
| Clone Cells | 1 | 2020 | 312 | 0.05 | Why? |
| Tumor Necrosis Factor-alpha | 2 | 2020 | 2483 | 0.05 | Why? |
| Cell Compartmentation | 1 | 2019 | 24 | 0.05 | Why? |
| Immunoglobulin G | 2 | 2020 | 21571 | 0.05 | Why? |
| Betacoronavirus | 2 | 2020 | 204454 | 0.05 | Why? |
| Injections, Subcutaneous | 1 | 2021 | 647 | 0.05 | Why? |
| Sequence Analysis | 1 | 2020 | 496 | 0.05 | Why? |
| Haptens | 1 | 2017 | 7 | 0.05 | Why? |
| Mutation | 1 | 2019 | 12376 | 0.05 | Why? |
| Interleukin-18 | 1 | 2020 | 328 | 0.05 | Why? |
| Interleukin Receptor Common gamma Subunit | 1 | 2017 | 24 | 0.05 | Why? |
| Homozygote | 1 | 2019 | 230 | 0.04 | Why? |
| Muromegalovirus | 1 | 2017 | 16 | 0.04 | Why? |
| Natural Cytotoxicity Triggering Receptor 2 | 1 | 2017 | 4 | 0.04 | Why? |
| Siblings | 1 | 2019 | 226 | 0.04 | Why? |
| Natural Cytotoxicity Triggering Receptor 3 | 1 | 2017 | 14 | 0.04 | Why? |
| Natural Cytotoxicity Triggering Receptor 1 | 1 | 2017 | 21 | 0.04 | Why? |
| Biomedical Research | 1 | 2018 | 5270 | 0.04 | Why? |
| Antibodies, Viral | 2 | 2020 | 51949 | 0.04 | Why? |
| Mice, SCID | 1 | 2017 | 225 | 0.04 | Why? |
| Aged, 80 and over | 4 | 2020 | 88759 | 0.04 | Why? |
| NK Cell Lectin-Like Receptor Subfamily C | 1 | 2017 | 52 | 0.04 | Why? |
| Interleukin-2 | 1 | 2019 | 443 | 0.04 | Why? |
| In Vitro Techniques | 1 | 2020 | 1027 | 0.04 | Why? |
| Single-Blind Method | 1 | 2021 | 1283 | 0.04 | Why? |
| Pandemics | 4 | 2020 | 389249 | 0.04 | Why? |
| Male | 7 | 2021 | 367725 | 0.04 | Why? |
| Lymphocytes | 2 | 2021 | 3056 | 0.04 | Why? |
| Glycosylation | 1 | 2020 | 1255 | 0.04 | Why? |
| Primary Cell Culture | 1 | 2017 | 501 | 0.04 | Why? |
| Interleukin-1beta | 1 | 2020 | 992 | 0.04 | Why? |
| Treatment Failure | 1 | 2021 | 2106 | 0.04 | Why? |
| Primates | 1 | 2017 | 584 | 0.03 | Why? |
| Cell Line | 2 | 2021 | 12040 | 0.03 | Why? |
| Interleukin-8 | 1 | 2020 | 964 | 0.03 | Why? |
| Cell Differentiation | 1 | 2020 | 1338 | 0.03 | Why? |
| Receptors, Immunologic | 1 | 2017 | 555 | 0.03 | Why? |
| Alveolar Epithelial Cells | 1 | 2020 | 1445 | 0.03 | Why? |
| Cytomegalovirus Infections | 1 | 2019 | 667 | 0.03 | Why? |
| Young Adult | 2 | 2021 | 93724 | 0.03 | Why? |
| Interleukin-6 | 2 | 2020 | 7522 | 0.03 | Why? |
| Interleukin 1 Receptor Antagonist Protein | 1 | 2020 | 1165 | 0.03 | Why? |
| Autoimmunity | 1 | 2019 | 841 | 0.03 | Why? |
| Cell Proliferation | 1 | 2019 | 1973 | 0.03 | Why? |
| Antigens, CD | 1 | 2017 | 984 | 0.03 | Why? |
| United States | 1 | 2018 | 46150 | 0.03 | Why? |
| HIV Infections | 1 | 2015 | 11620 | 0.02 | Why? |
| Rituximab | 1 | 2017 | 1096 | 0.02 | Why? |
| Immunoglobulin A | 1 | 2020 | 3567 | 0.02 | Why? |
| Outpatients | 1 | 2021 | 3417 | 0.02 | Why? |
| Transcriptome | 1 | 2021 | 3466 | 0.02 | Why? |
| Phenotype | 1 | 2019 | 4037 | 0.02 | Why? |
| Antiviral Agents | 1 | 2021 | 41703 | 0.02 | Why? |
| Lymphocyte Activation | 1 | 2017 | 2742 | 0.02 | Why? |
| Antibody Formation | 1 | 2020 | 4038 | 0.02 | Why? |
| HEK293 Cells | 1 | 2020 | 8394 | 0.02 | Why? |
| Adaptive Immunity | 1 | 2017 | 2585 | 0.02 | Why? |
| Enzyme-Linked Immunosorbent Assay | 1 | 2020 | 7868 | 0.02 | Why? |
| Renin-Angiotensin System | 1 | 2020 | 3661 | 0.02 | Why? |
| Epitopes | 1 | 2017 | 4113 | 0.02 | Why? |
| Lymphocyte Count | 1 | 2017 | 4758 | 0.02 | Why? |
| Models, Molecular | 1 | 2019 | 7616 | 0.02 | Why? |
| Asymptomatic Diseases | 1 | 2017 | 3444 | 0.02 | Why? |
| Virus Shedding | 1 | 2021 | 5834 | 0.02 | Why? |
| Signal Transduction | 1 | 2019 | 7207 | 0.01 | Why? |
| Real-Time Polymerase Chain Reaction | 1 | 2020 | 11367 | 0.01 | Why? |
| CD8-Positive T-Lymphocytes | 1 | 2017 | 5837 | 0.01 | Why? |
| Antigens, Viral | 1 | 2017 | 6298 | 0.01 | Why? |
| Spike Glycoprotein, Coronavirus | 2 | 2020 | 37182 | 0.01 | Why? |
| Disease Models, Animal | 1 | 2017 | 10998 | 0.01 | Why? |
| Age Factors | 1 | 2017 | 21039 | 0.01 | Why? |
| Vaccination | 1 | 2021 | 19050 | 0.01 | Why? |
| Antibodies, Neutralizing | 1 | 2020 | 25288 | 0.01 | Why? |
| Treatment Outcome | 1 | 2019 | 51732 | 0.01 | Why? |
| Child | 1 | 2020 | 70012 | 0.01 | Why? |
| Adolescent | 1 | 2020 | 86841 | 0.01 | Why? |
Blish's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(159)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(188)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_